0J3X Stock Overview
Cofinimmo has been acquiring, developing and managing rental properties for 40 years.
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 3/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 5/6 |
Rewards
Risk Analysis
Cofinimmo SA Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €62.24 |
52 Week High | €87.30 |
52 Week Low | €53.60 |
Beta | 0.71 |
1 Month Change | 9.26% |
3 Month Change | -7.71% |
1 Year Change | -26.83% |
3 Year Change | -51.60% |
5 Year Change | -46.16% |
Change since IPO | -51.77% |
Recent News & Updates
Recent updates
Shareholder Returns
0J3X | GB Health Care REITs | GB Market | |
---|---|---|---|
7D | -1.2% | -2.2% | -0.7% |
1Y | -26.8% | -15.2% | -1.8% |
Return vs Industry: 0J3X underperformed the UK Health Care REITs industry which returned -15.2% over the past year.
Return vs Market: 0J3X underperformed the UK Market which returned -1.8% over the past year.
Price Volatility
0J3X volatility | |
---|---|
0J3X Average Weekly Movement | 2.9% |
Health Care REITs Industry Average Movement | 2.8% |
Market Average Movement | 4.8% |
10% most volatile stocks in GB Market | 11.5% |
10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0J3X has not had significant price volatility in the past 3 months.
Volatility Over Time: 0J3X's weekly volatility (3%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1983 | 155 | Jean-Pierre Hanin | www.cofinimmo.com |
Cofinimmo has been acquiring, developing and managing rental properties for 40 years. The company has a portfolio spread across Belgium, France, the Netherlands, Germany, Spain, Finland, Ireland, Italy and the United Kingdom, with a value of approximately 6.2 billion EUR. Responding to societal changes, Cofinimmo’s mission is to provide high-quality care, living, and working spaces to partner-tenants that directly benefit their occupants.
Cofinimmo SA Fundamentals Summary
0J3X fundamental statistics | |
---|---|
Market cap | €2.29b |
Earnings (TTM) | -€55.50m |
Revenue (TTM) | €388.97m |
5.9x
P/S Ratio-41.2x
P/E RatioIs 0J3X overvalued?
See Fair Value and valuation analysisEarnings & Revenue
0J3X income statement (TTM) | |
---|---|
Revenue | €388.97m |
Cost of Revenue | €102.19m |
Gross Profit | €286.78m |
Other Expenses | €342.28m |
Earnings | -€55.50m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 26, 2024
Earnings per share (EPS) | -1.51 |
Gross Margin | 73.73% |
Net Profit Margin | -14.27% |
Debt/Equity Ratio | 74.3% |
How did 0J3X perform over the long term?
See historical performance and comparison